Thrivent Financial for Lutherans’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $816K | Buy |
12,511
+321
| +3% | +$20.9K | ﹤0.01% | 1908 |
|
|
2025
Q1 | $816K | Sell |
12,190
-638
| -5% | -$42.7K | ﹤0.01% | 1842 |
|
|
2024
Q4 | $709K | Sell |
12,828
-200
| -2% | -$11.1K | ﹤0.01% | 2087 |
|
|
2024
Q3 | $777K | Buy |
13,028
+299
| +2% | +$17.8K | ﹤0.01% | 2054 |
|
|
2024
Q2 | $811K | Sell |
12,729
-349
| -3% | -$22.2K | ﹤0.01% | 1981 |
|
|
2024
Q1 | $904K | Sell |
13,078
-356
| -3% | -$24.6K | ﹤0.01% | 1949 |
|
|
2023
Q4 | $741K | Sell |
13,434
-1,223
| -8% | -$67.5K | ﹤0.01% | 2027 |
|
|
2023
Q3 | $851K | Buy |
14,657
+1,337
| +10% | +$77.6K | ﹤0.01% | 1845 |
|
|
2023
Q2 | $717K | Buy |
13,320
+1,212
| +10% | +$65.2K | ﹤0.01% | 2013 |
|
|
2023
Q1 | $481K | Sell |
12,108
-424
| -3% | -$16.8K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $504K | Buy |
12,532
+60
| +0.5% | +$2.41K | ﹤0.01% | 2114 |
|
|
2022
Q3 | $401K | Sell |
12,472
-397
| -3% | -$12.8K | ﹤0.01% | 2152 |
|
|
2022
Q2 | $382K | Buy |
12,869
+2,511
| +24% | +$74.5K | ﹤0.01% | 2191 |
|
|
2022
Q1 | $291K | Buy |
10,358
+1,550
| +18% | +$43.5K | ﹤0.01% | 2351 |
|
|
2021
Q4 | $406K | Buy |
8,808
+974
| +12% | +$44.9K | ﹤0.01% | 2252 |
|
|
2021
Q3 | $257K | Sell |
7,834
-283
| -3% | -$9.28K | ﹤0.01% | 2375 |
|
|
2021
Q2 | $284K | Buy |
8,117
+205
| +3% | +$7.17K | ﹤0.01% | 2346 |
|
|
2021
Q1 | $286K | Sell |
7,912
-1,493
| -16% | -$54K | ﹤0.01% | 2399 |
|
|
2020
Q4 | $273K | Buy |
9,405
+1,458
| +18% | +$42.3K | ﹤0.01% | 2335 |
|
|
2020
Q3 | $224K | Hold |
7,947
| – | – | ﹤0.01% | 2264 |
|
|
2020
Q2 | $257K | Buy |
7,947
+151
| +2% | +$4.88K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $318K | Buy |
7,796
+390
| +5% | +$15.9K | ﹤0.01% | 1952 |
|
|
2019
Q4 | $457K | Buy |
7,406
+19
| +0.3% | +$1.17K | ﹤0.01% | 1931 |
|
|
2019
Q3 | $538K | Buy |
7,387
+879
| +14% | +$64K | ﹤0.01% | 1796 |
|
|
2019
Q2 | $535K | Buy |
6,508
+182
| +3% | +$15K | ﹤0.01% | 1793 |
|
|
2019
Q1 | $446K | Buy |
6,326
+475
| +8% | +$33.5K | ﹤0.01% | 1853 |
|
|
2018
Q4 | $263K | Sell |
5,851
-500
| -8% | -$22.5K | ﹤0.01% | 1847 |
|
|
2018
Q3 | $359K | Buy |
6,351
+125
| +2% | +$7.07K | ﹤0.01% | 1821 |
|
|
2018
Q2 | $416K | Buy |
6,226
+429
| +7% | +$28.7K | ﹤0.01% | 1771 |
|
|
2018
Q1 | $338K | Buy |
5,797
+186
| +3% | +$10.8K | ﹤0.01% | 1820 |
|
|
2017
Q4 | $362K | Buy |
5,611
+111
| +2% | +$7.16K | ﹤0.01% | 1833 |
|
|
2017
Q3 | $289K | Buy |
5,500
+660
| +14% | +$34.7K | ﹤0.01% | 1800 |
|
|
2017
Q2 | $227K | Buy |
4,840
+320
| +7% | +$15K | ﹤0.01% | 1831 |
|
|
2017
Q1 | $224K | Buy |
4,520
+220
| +5% | +$10.9K | ﹤0.01% | 1814 |
|
|
2016
Q4 | $261K | Buy |
4,300
+240
| +6% | +$14.6K | ﹤0.01% | 1766 |
|
|
2016
Q3 | $269K | Buy |
4,060
+400
| +11% | +$26.5K | ﹤0.01% | 1746 |
|
|
2016
Q2 | $204K | Buy |
+3,660
| New | +$204K | ﹤0.01% | 1790 |
|